Más allá de las inversiones en Celiac
What is Beyond Celiac Investments?
Beyond Celiac Investments (BCI) accelerates the development of treatments toward a cure for celiac disease by leveraging the speed and scale of venture capital and capital markets. BCI launched in February of 2024 with an initial funding of $2 million.
Why Was Beyond Celiac Investments Created?
Beyond Celiac developed BCI to accelerate drug development using the proven venture philanthropy model. Before the launch of BCI, no celiac or autoimmune-focused venture funds existed.
A nonprofit approach supports identifying and investing significant resources into promising treatments already in development, including those approved for other uses that might also benefit celiac disease patients.
Further, because of BCI’s nonprofit structure, all financial returns are reinvested into Beyond Celiac for future investments and grants, generating ongoing growth of support for the celiac disease community.
